Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Stock
NASDAQ · ZYBT
1.37
Fundamentals
Market cap
$64.93M
Price / Earnings ratio
-6.3x
Price / Sales ratio
3.9x
Price / Book ratio
1.8x
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Zhengye Biotechnology Holding Limited Ordinary Shares
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees269
CEOMr. Songlin Song
IPO DateJan 7, 2025
HeadquartersJilin, China
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Songlin Song | Co-Chief Executive Officer | 1976 |
| Mr. Ping Wang | Chief Financial Officer | 1981 |
| Mr. Zhongyao Liu | Chief Operating Officer | 1986 |
| Ms. Yuhong Cheng | Vice General Manager | 1977 |
| Mr. Aiden Han | Co-Chief Executive Officer | 1993 |
Fundamentals
Valuation
Market cap$64.93M
Price-to-sales ratio3.93
Price-to-book value1.83
Price-earnings ratio-6.30
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.21
Income Statement
Average volume138,530
EBITDAN/A
1 year high (52w)$10.12
1 year low (52w)$0.62
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



